{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:08:32Z","timestamp":1793214512890,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY026593"],"award-info":[{"award-number":["R01 EY026593"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ajo.2021.03.044","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T22:05:46Z","timestamp":1620684346000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis"],"prefix":"10.1016","volume":"228","author":[{"given":"Douglas A.","family":"Jabs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair K.","family":"Denniston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Oden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle A.","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Palestine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell W.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett E.","family":"Trusko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9648","key":"10.1016\/j.ajo.2021.03.044_bib0001","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.044_bib0002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/17469899.2017.1264875","article-title":"Multiple sclerosis-associated uveitis","volume":"12","author":"Vadboncoeur","year":"2017","journal-title":"Expert Rev Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2021.03.044_bib0003","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States a population-based estimate using health claims data","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ajo.2021.03.044_bib0004","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria","volume":"58","author":"Ch","year":"2005","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.044_bib0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.044_bib0006","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.044_bib0007","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ophtha.2018.10.013","article-title":"Uveitis in patients with multiple sclerosis in clinical trials of fingolimod. Incidence, prevalence, and impact on disease course","volume":"126","author":"Lim","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.03.044_bib0008","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archopht.1962.00960030506014","article-title":"Epidemiology of uveitis","volume":"68","author":"Darrell","year":"1962","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.044_bib0009","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0420.1995.tb00040.x","article-title":"Epidemiology of endogenous uveitis in southwest Finland","volume":"73","author":"Saari","year":"1995","journal-title":"Acta Ophthalmologica Scan"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.044_bib0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","article-title":"Incidence and prevalence of uveitis in northern California: the Northern California Epidemiology of Uveitis study","volume":"111","author":"Gritz","year":"2004","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.044_bib0011","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Nussenblatt RB for the Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Report of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.044_bib0012","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajo.2013.03.027","article-title":"Approach to the diagnosis of the uveitides","volume":"156","author":"Jabs","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.044_bib0013","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archopht.1960.01840010542010","article-title":"Peripheral posterior segment inflammation, vitreous opacities, and edema of the posterior pole","volume":"64","author":"Welch","year":"1960","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.044_bib0014","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0002-9394(60)91340-4","article-title":"Uveitis II. Peripheral uveitis: clinical description, complications and differential diagnosis","volume":"49","author":"Brockhurst","year":"1960","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2021.03.044_bib0015","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0161-6420(93)31567-8","article-title":"Long-term visual outcome and complications associated with pars planitis","volume":"100","author":"Malinowski","year":"1993","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.044_bib0016","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0161-6420(99)90122-7","article-title":"Pars planitis: clinical features and class II HLA associations","volume":"106","author":"Raja","year":"1999","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2021.03.044_bib0017","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ajo.2007.08.023","article-title":"Pars planitis: a 20-year study of incidence, clinical features, and outcomes","volume":"144","author":"Donaldson","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"1-2","key":"10.1016\/j.ajo.2021.03.044_bib0018","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-510X(01)00520-2","article-title":"Patients with multiple sclerosis and concomitant uveitis\/periphlebitis retinae are not distinct form those without intraocular inflammation","volume":"187","author":"Schmidt","year":"2001","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.044_bib0019","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3414\/ME12-01-0063","article-title":"Standardization of Uveitis Nomenclature Working Group. The SUN Project. Development of a clinical evidence base utilizing informatics tools and techniques","volume":"52","author":"Trusko","year":"2013","journal-title":"Methods Inf Med"},{"key":"10.1016\/j.ajo.2021.03.044_bib0020","first-page":"787","article-title":"The SUN project. The future is here","volume":"131","author":"Okada","year":"2013","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.044_bib0021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajo.2017.10.028","article-title":"for the Standardization of Uveitis Nomenclature Working Group. Interobserver agreement among uveitis experts on uveitic diagnoses: the Standard of Uveitis Nomenclature experience","volume":"186","author":"Jabs","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2021.03.044_bib0022","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/acr.22583","article-title":"Distinctions between diagnostic and classification criteria","volume":"67","author":"Aggarwal","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ajo.2021.03.044_bib0023","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Development of classification criteria for the uveitides","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.044_bib0024","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for pars planitis","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2021.03.044_bib0025","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0161-6420(93)31505-8","article-title":"The association of HLA-B8, B51, DR2 and multiple sclerosis in pars planitis","volume":"100","author":"Malinowski","year":"1993","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.044_bib0026","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ajo.2009.09.018","article-title":"HLA typing in uveitis; use and misuse","volume":"149","author":"Zamecki","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2021.03.044_bib0027","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bjophthalmol-2015-307269","article-title":"Intermediate uveitis and multiple sclerosis: to scan or not to scan","volume":"99","author":"Petrushkin","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2021.03.044_bib0028","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0002-9394(89)90856-8","article-title":"Ocular Lyme borreliosis","volume":"108","author":"Winward","year":"1989","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.044_bib0029","first-page":"181","article-title":"Intermediate uveitis and Lyme borreliosis","volume":"76","author":"Breeveld","year":"1992","journal-title":"Br Med J"},{"key":"10.1016\/j.ajo.2021.03.044_bib0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ajo.2016.04.002","article-title":"No value for routine screening for Borrelia burgdorferi in patients with uveitis in the Netherlands","volume":"166","author":"Kazi","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2021.03.044_bib0031","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.ophtha.2019.06.014","article-title":"Usefulness of routine Lyme screening in patients with uveitis","volume":"126","author":"Caplash","year":"2019","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.044_bib0032","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421001690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421001690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:43:22Z","timestamp":1762080202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":32,"alternative-id":["S0002939421001690"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.03.044","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.03.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}